Discordance between amyloid-β PET and CSF biomarkers : clinical and pathophysiological consequences = Amüloid-β staatuse vastuolu PET-uuringul ning liikvorianalüüsil : kliiniline ja patofüsioloogiline tähendusReimand, Juhan2021 https://doi.org/10.23658/taltech.15/2021 https://www.ester.ee/record=b5431268*est https://digikogu.taltech.ee/et/Item/d14a365f-fbfc-4595-923e-473262485fe2

Discordant amyloid-β PET and CSF biomarkers and its clinical consequencesWilde, Arno de; Reimand, Juhan; Teunissen, Charlotte E.; Zwan, MarissaAlzheimer's Research & Therapy2019 / art. 78, 13 p. : ill https://doi.org/10.1186/s13195-019-0532-x Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS

Why is amyloid-β PET requested after performing CSF biomarkers?Reimand, Juhan; Groot, Colin; Teunissen, Charlotte E.; Windhorst, Albert D.; Boellaard, Ronald; Barkhof, Frederike; Nazarenko, Sergei; van der Flier, Wiesje M.; Scheltens, Philip; Ossenkoppele, Rik; Bouwman, FemkeJournal of Alzheimer's disease2020 / p. 559-569 https://doi.org/10.3233/JAD-190836 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS